What Causes Low HDL?: A Functional-Medicine Lens on Causes and Support

What Causes Low HDL? Understanding the Full Picture

HDL (high-density lipoprotein) is often called the "good" cholesterol, but that label undersells its true role. HDL particles don't just ferry cholesterol away from arterial walls through a process called reverse cholesterol transport—they also carry anti-inflammatory proteins, modulate immune responses, and protect the vascular endothelium. When HDL falls below optimal range, the cardiovascular and metabolic consequences run far deeper than a single lab value suggests.

The American Heart Association notes that low HDL is an independent risk factor for coronary artery disease, even when LDL is well-controlled. But the question functional-medicine clinicians ask isn't just how low is it—it's why is it low. Identifying the upstream driver is what separates a targeted intervention from a generic lifestyle pep talk.

---

What Causes HDL to Be Out of Range?

Low HDL rarely has a single cause. Most cases reflect a cluster of overlapping metabolic and lifestyle factors that suppress HDL synthesis, accelerate HDL catabolism, or both.

1. Insulin Resistance and Metabolic Syndrome

Insulin resistance is arguably the single most common driver of low HDL in Western populations. Elevated insulin upregulates hepatic lipase activity, an enzyme that accelerates the breakdown of mature HDL particles. In a large cross-sectional analysis published in Circulation, each unit increase in HOMA-IR (a surrogate for insulin resistance) was independently associated with lower HDL-C and higher triglycerides—the classic dyslipidemia pattern of metabolic syndrome (Reaven et al., Circulation 2005; PMID: 15655130).

This explains why triglycerides and HDL move in opposite directions so reliably: both are downstream effects of the same insulin-signaling problem.

2. Chronic Systemic Inflammation

Inflammatory cytokines—particularly TNF-α and IL-6—suppress the gene expression of ApoA-1, the primary structural protein of HDL particles. Without adequate ApoA-1, the liver cannot assemble functional HDL. A landmark study from the Journal of the American College of Cardiology demonstrated that elevated hsCRP was inversely correlated with HDL-C and that the relationship was mediated partly through ApoA-1 suppression (Ridker et al., JACC 2003; PMID: 12742300).

Sources of chronic low-grade inflammation that frequently appear in clinical practice include visceral adiposity, poor gut barrier integrity, sleep deprivation, and environmental toxin burden.

3. Dietary Patterns: Trans Fats, Excess Refined Carbohydrates, and Low Dietary Fat

Despite decades of low-fat dietary dogma, dietary fat—particularly monounsaturated and saturated fat in appropriate context—is a meaningful driver of HDL synthesis. Diets high in refined carbohydrates raise triglycerides and lower HDL by stimulating de novo lipogenesis in the liver. Industrial trans fats, now largely banned in the US but still present in some processed imports, both raise LDL and lower HDL simultaneously.

A meta-analysis in The American Journal of Clinical Nutrition confirmed that replacing carbohydrates with monounsaturated fats reliably raises HDL without adverse LDL effects (Mensink et al., Am J Clin Nutr 2003; PMID: 12716665).

4. Physical Inactivity

Aerobic exercise directly upregulates lecithin-cholesterol acyltransferase (LCAT), an enzyme critical to HDL maturation. Resistance training contributes via improved insulin sensitivity. The dose-response relationship between cardiorespiratory fitness and HDL-C is well-established, though most guidelines understate the intensity required—low-moderate intensity walking produces modest HDL gains; vigorous aerobic exercise (≥70% VO2 max for 20+ minutes, three times weekly) produces meaningfully larger increases.

5. Smoking and Alcohol Dysregulation

Cigarette smoking oxidizes HDL particles, rendering them dysfunctional even when particle count appears normal. Smoking cessation raises HDL-C by an average of 4 mg/dL within one year. Moderate alcohol intake paradoxically raises HDL-C through increased ApoA-1 synthesis, which is one reason some epidemiological studies show a J-curve—but heavy alcohol use shifts the balance toward hepatic damage and net HDL suppression.

6. Genetic Factors: Familial Low HDL and ApoA-1 Mutations

Tangier disease and familial hypoalphalipoproteinemia represent rare monogenic causes of extremely low HDL. More commonly, polygenic variants reduce HDL modestly but clinically meaningfully. Genetic susceptibility doesn't mean HDL cannot be improved—but it does mean that lifestyle and supplement interventions need to work harder, and the ceiling for improvement may be lower.

---

The Thyroid–HDL Connection: Why Thyroid Markers Matter on a Lipid Panel

This is where functional-medicine thinking diverges sharply from conventional cardiology: thyroid dysfunction is a frequently missed driver of low HDL, and it operates through several intersecting pathways.

What Causes TSH to Be Out of Range and Its Impact on HDL?

Hypothyroidism—even subclinical hypothyroidism with TSH in the 3–5 mIU/L range—slows the expression of LDL receptors in the liver and reduces the activity of CETP (cholesteryl ester transfer protein), which participates in reverse cholesterol transport. The net result is a lipid profile that features elevated total cholesterol, elevated LDL, and suppressed HDL. In a prospective study published in Thyroid, patients with TSH above 4.0 mIU/L demonstrated significantly lower HDL-C compared to euthyroid controls, with the relationship persisting after adjustment for BMI and metabolic syndrome criteria (Duntas & Brenta, Thyroid 2012; PMID: 22224888).

This means a low HDL finding on bloodwork should always prompt a full thyroid panel—not just TSH, but free T4, free T3, and ideally thyroid antibodies.

What Causes Free T4 to Be Out of Range?

Free T4 (thyroxine) is the primary secretory product of the thyroid gland. Low free T4, even when TSH is still within the "normal" lab range, can indicate central hypothyroidism (a pituitary failure to adequately drive the thyroid), early-stage autoimmune thyroiditis, iodine deficiency, or selenium deficiency that impairs thyroglobulin synthesis. Because free T4 is the precursor to the metabolically active T3, a low-normal or below-range free T4 is a meaningful signal that downstream thyroid activity may be compromised—including the enzyme cascades that regulate HDL synthesis and reverse cholesterol transport.

Nutrients that support healthy free T4 levels include iodine, selenium, iron (required for thyroid peroxidase function), and zinc.

What Causes Free T3 to Be Out of Range?

Free T3 is the biologically active thyroid hormone, converted from T4 primarily by deiodinase enzymes in the liver and peripheral tissues—and these enzymes are selenium-dependent. Low free T3, sometimes called "low T3 syndrome" or "euthyroid sick syndrome" in severe illness, can also appear in the context of chronic stress (cortisol inhibits T4-to-T3 conversion), selenium deficiency, and systemic inflammation. Functionally, low free T3 means cells receive reduced metabolic signaling—including the hepatocytes responsible for synthesizing ApoA-1 and assembling HDL particles. This is a direct, mechanistic pathway from thyroid dysfunction to low HDL that is rarely discussed in standard lipid management guidelines.

For individuals with low HDL and low-normal free T3, supporting T4-to-T3 conversion through selenium optimization and stress-axis support is a rational, evidence-informed strategy. To understand how stress hormones intersect with thyroid conversion, how adrenal dysfunction affects thyroid function is a topic worth exploring in detail.

---

Nutritional Drivers of Low HDL: The Micronutrient Angle

Beyond macronutrient composition, several micronutrient deficiencies directly impair HDL metabolism:

Omega-3 supplementation deserves special emphasis. A meta-analysis in Atherosclerosis encompassing over 4,000 participants found that EPA+DHA supplementation at 2–4g/day reduced triglycerides by 20–30% without adversely affecting HDL, and in some subgroups produced modest HDL increases—particularly in individuals with baseline hypertriglyceridemia (Eslick et al., Atherosclerosis 2009; PMID: 18774155).

For individuals also managing omega-3 dosing for cardiovascular risk, the intersection with HDL optimization is clinically significant.

---

Lifestyle Interventions with the Strongest HDL Evidence

Before or alongside supplementation, these lifestyle changes have the clearest clinical evidence:

1. Increase vigorous aerobic exercise — 150 minutes per week at moderate-to-high intensity raises HDL-C by 3–5 mg/dL on average.
2. Reduce refined carbohydrate and sugar intake — targets the triglyceride-HDL axis driven by insulin resistance.
3. Increase dietary monounsaturated fats — olive oil, avocado, and nuts improve the HDL/LDL ratio.
4. Quit smoking — HDL-C rises 4+ mg/dL within 12 months of cessation.
5. Optimize sleep — sleep deprivation raises inflammatory cytokines that suppress ApoA-1.
6. Reduce visceral fat — even a 5–10% reduction in body weight produces meaningful HDL improvement.

---

What This Means for Your Formula

A functional-medicine approach to low HDL doesn't prescribe a single supplement—it maps the individual's upstream drivers from lab data and builds a targeted stack accordingly. This is precisely where Ones adds clinical leverage.

For individuals whose low HDL is tied to insulin resistance and elevated triglycerides, Ones includes Omega-3 (EPA/DHA) dosed in the clinically effective 2–4g range. The evidence from multiple RCTs confirms that this dose range produces meaningful triglyceride reduction, which reliably improves the triglyceride-to-HDL ratio—one of the most actionable markers on a standard lipid panel.

For individuals whose bloodwork suggests thyroid underfunction contributing to low HDL—particularly low-normal free T3 or low-normal free T4—Ones offers its proprietary Thyroid Support blend, formulated to provide nutrients that support thyroid hormone synthesis and T4-to-T3 conversion, including selenium in selenomethionine form. This targets the enzymatic bottleneck at the deiodinase step that directly impacts hepatic HDL assembly.

For those where chronic inflammation and HPA-axis dysregulation are driving both low HDL and low free T3 conversion, Ones incorporates Ashwagandha KSM-66 at 600mg—the clinically validated dose shown in a 60-person RCT to reduce serum cortisol by 27.9% over 60 days (Chandrasekhar et al., Indian J Psychol Med 2012; PMID: 23439798). Chronically elevated cortisol both suppresses T4-to-T3 conversion and promotes the visceral adiposity pattern that independently lowers HDL.

Each Ones formula is built by the platform's AI health practitioner after analyzing your actual blood work and, where available, wearable data—so the stack addresses your specific HDL drivers, not a generic low-HDL template. To learn more about how personalized supplement formulas are built from lab data, the process is worth reviewing before your next panel.

---

Key Takeaways

• Low HDL is rarely caused by one factor—insulin resistance, chronic inflammation, thyroid dysfunction, dietary patterns, and physical inactivity commonly co-occur and compound each other.
• Thyroid markers (TSH, free T4, free T3) should always be evaluated alongside a lipid panel; subclinical hypothyroidism is a frequently missed and treatable cause of low HDL.
• Low free T3, driven by selenium deficiency, stress, or inflammation, impairs the hepatic machinery responsible for ApoA-1 synthesis and HDL assembly.
• Omega-3 supplementation at 2–4g EPA+DHA per day is among the most evidence-backed nutritional interventions for improving the triglyceride-to-HDL ratio.
• Lifestyle interventions—particularly vigorous aerobic exercise and reduction of refined carbohydrates—produce the largest absolute HDL gains and should anchor any protocol.
• A functional, data-driven platform like Ones can map your specific HDL drivers from blood work and build a targeted formula rather than a one-size-fits-all approach.